[{"target":17,"price":4.950,"returns":243,"ticker":"CCO","note":"Cameco (TSE:CCO) Given New C$17.00 Price Target at BMO Capital Markets - Riverton Roll","to_char":"07/12/2019","q_eps":null,"a_eps":-0.700,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":163,"price":64.590,"returns":152,"ticker":"DWDP","note":"DowDuPont Inc (NYSE:DWDP) Receives $163.89 Average Target Price from Analysts - Riverton Roll","to_char":"07/13/2019","q_eps":null,"a_eps":0.000,"report":"analyst","q_pe":null,"a_pe":null,"divyield":0.050},{"target":12,"price":5.030,"returns":129,"ticker":"PCYG","note":"Park City Group, Inc. (NASDAQ:PCYG) Given $11.50 Consensus Target Price by Brokerages - Riverton Roll","to_char":"07/14/2019","q_eps":null,"a_eps":0.220,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":21,"price":9.770,"returns":115,"ticker":"AKBA","note":"Analysts at HC Wainwright Maintained their Past 'Buy' rating on Shares Akebia Therapeutics (NASDAQ:AKBA), Set a $21 Target - Invest Tribune","to_char":"07/11/2019","q_eps":null,"a_eps":-2.560,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":5,"price":2.450,"returns":104,"ticker":"NBR","note":"Nabors Industries (NYSE:NBR) Given New $5.00 Price Target at Morgan Stanley - Riverton Roll","to_char":"07/13/2019","q_eps":null,"a_eps":-1.880,"report":"analyst","q_pe":null,"a_pe":null,"divyield":0.078}]
